Home

Terminál folyékony zselé tap73 is a marker of glutamine addiction in medulloblastoma Városközpont szökőkút próba

Brain tumour's 'addiction' to common amino acid could be its weakness
Brain tumour's 'addiction' to common amino acid could be its weakness

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse  brain and suppresses the growth of MYC-driven medulloblastoma -  ScienceDirect
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma - ScienceDirect

Glutamine metabolism, the Achilles heel for medulloblastoma tumor | Cell  Death & Disease
Glutamine metabolism, the Achilles heel for medulloblastoma tumor | Cell Death & Disease

TAp73 is a marker of glutamine addiction in medulloblastoma
TAp73 is a marker of glutamine addiction in medulloblastoma

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse  brain and suppresses the growth of MYC-driven medullob
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medullob

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through  hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through  hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink

TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract -  Europe PMC
TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract - Europe PMC

Molecules | Free Full-Text | Identification of Therapeutic Targets for  Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model

Frontiers | p73 as a Tissue Architect
Frontiers | p73 as a Tissue Architect

Glutamine metabolism, the Achilles heel for medulloblastoma tumor | Cell  Death & Disease
Glutamine metabolism, the Achilles heel for medulloblastoma tumor | Cell Death & Disease

NPI-0052 and γ-radiation induce a synergistic apoptotic effect in  medulloblastoma | Cell Death & Disease
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma | Cell Death & Disease

TAp73 is a marker of glutamine addiction in medulloblastoma
TAp73 is a marker of glutamine addiction in medulloblastoma

Molecules | Free Full-Text | Identification of Therapeutic Targets for  Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model

Cancers | Free Full-Text | Role of MicroRNAs in the Development and  Progression of the Four Medulloblastoma Subgroups
Cancers | Free Full-Text | Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups

Molecules | Free Full-Text | Identification of Therapeutic Targets for  Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model
Molecules | Free Full-Text | Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model

The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma  cells - Varon - 2019 - International Journal of Cancer - Wiley Online  Library
The long noncoding RNA TP73‐AS1 promotes tumorigenicity of medulloblastoma cells - Varon - 2019 - International Journal of Cancer - Wiley Online Library

TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract -  Europe PMC
TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract - Europe PMC

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through  hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink
Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer | SpringerLink

Frontiers | Targeting Glutaminolysis: New Perspectives to Understand Cancer  Development and Novel Strategies for Potential Target Therapies
Frontiers | Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies

Cancer metabolism and dietary interventions | Cancer Biology & Medicine
Cancer metabolism and dietary interventions | Cancer Biology & Medicine

PDF) TAp73 is a marker of glutamine addiction in medulloblastoma
PDF) TAp73 is a marker of glutamine addiction in medulloblastoma

PDF) TAp73 is a marker of glutamine addiction in medulloblastoma
PDF) TAp73 is a marker of glutamine addiction in medulloblastoma

TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract -  Europe PMC
TAp73 is a marker of glutamine addiction in medulloblastoma. - Abstract - Europe PMC

PDF) TAp73 is a marker of glutamine addiction in medulloblastoma
PDF) TAp73 is a marker of glutamine addiction in medulloblastoma

Brain Tumor's 'Addiction' To Common Amino Acid Could Be Its Weakness
Brain Tumor's 'Addiction' To Common Amino Acid Could Be Its Weakness